Net Worth Advisory Group Regeneron Pharmaceuticals, Inc. Transaction History
Net Worth Advisory Group
- $337 Billion
- Q3 2024
A detailed history of Net Worth Advisory Group transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Net Worth Advisory Group holds 1,946 shares of REGN stock, worth $1.94 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
1,946Holding current value
$1.94 Million% of portfolio
0.61%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,468Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$8.98 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.43 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.26 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.83 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.63 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $107B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...